Top Markets
Coin of the day
AzurRx BioPharma, Inc. AzurRx BioPharma, Inc.

AzurRx BioPharma, Inc.

AZRX
Rangering i aksjer #35193
AzurRx BioPharma, Inc., a Brooklyn, New York-based company employing 12... AzurRx BioPharma, Inc., a Brooklyn, New York-based company employing 12 full-time individuals, focuses on the discovery and advancement of non-systemic biological treatments for various gastrointestinal conditions. Its current developmental portfolio comprises two therapeutic protein assets: MS1819 and AZX1101. MS1819 is an acid-stable lipase enzyme (LIP2), originating from Yarrowia lipolytica, which AzurRx is genetically engineering to address exocrine pancreatic insufficiency (EPI). EPI is a debilitating disorder often seen in patients with chronic pancreatitis (CP) and cystic fibrosis (CF). The second promising compound, AZX1101, is a recombinant beta-lactamase combination sourced from bacteria. This asset is being engineered with a dual aim: to avert nosocomial infections caused by resistant bacterial strains, especially after intravenous beta-lactam antibiotic administration, and to mitigate antibiotic-associated diarrhea (AAD).
Aksjekurs
$3.45
Sist synkronisert: 2021-09-21
Markedsverdi
$4.29M
Endring (1 dag)
2.07%
Endring (1 år)
0.00%
Land
US
Handel AzurRx BioPharma, Inc. (AZRX)

Kategori

Historikk for aksjesplitt for AzurRx BioPharma, Inc. (AZRX)
Aksjen AzurRx BioPharma, Inc. (symbol: AZRX) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 16, 2026.
Én AZRX-aksje kjøpt før Aug 16, 2026 tilsvarer i dag 0 AZRX-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE